OriGene Antibodies in recent publications
ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial British Journal of Cancer 109, 2096-2105 (15 October 2013)
Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain PNAS, vol. 110 no. 47: 19036–19041
FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer Cancer Res. 2013 Sep 1;73(17):5416-25
Identification of putative immunologic targets for colon cancer prevention based on conserved gene upregulation from preinvasive to malignant lesions.
Cancer Prevention Research, Jul 2013; 6: 666 - 674.
|View All Citations >>||
Home Gene of the month BRAF|
BRAF – Protein Kinase
The BRAF gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. BRAF plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. BRAF mutations are associated with cardiofaciocutaneous syndrome, a disease characterized by heart defects, mental retardation and a distinctive facial appearance. In addition, BRAF mutations have been associated with various cancers, including non-Hodgkin lymphoma, colorectal cancer, malignant melanoma, thyroid carcinoma, non-small cell lung carcinoma, and adenocarcinoma of lung.
OriGene offers the following BRAF related products
||BRAF Antibodies – TrueMABTM, extensively validated monoclonal antibodies|
TA500852 – WB, IHC, IF, FC reacts with Human
TA600011 – ELISA reacts with Human
More BRAF Antibodies
||BRAF Protein – Full length human BRAF protein|
TP311013 – BIOACTIVE!!! Expressed in HEK293 cells
||BRAF ORF clones – transfection ready DNA|
RC211013 – MYC-DDK tagged clone
SC126575 – untagged clone
|TR320276 – BRAF shRNA, performance guarantee|
SR300470 – BRAF siRNA, performance guarantee
For all 35 BRAF products please click here!